Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma: 7-year follow-up results.
Tobinai
Kensei
K
Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital, Tsukiji, Chuo-ku, Tokyo, Japan. ktobinai@ncc.go.jp
Ogura
Michinori
M
Itoh
Kuniaki
K
Kinoshita
Tomohiro
T
Hotta
Tomomitsu
T
Watanabe
Takashi
T
Morishima
Yasuo
Y
Igarashi
Tadahiko
T
Terauchi
Takashi
T
Ohashi
Yasuo
Y